Neutralizing Antibodies Protect against Oral Transmission of Lymphocryptovirus

Epstein-Barr virus (EBV) is a cancer-associated pathogen for which there is no vaccine. Successful anti-viral vaccines elicit antibodies that neutralize infectivity; however, it is unknown whether neutralizing antibodies prevent EBV acquisition. Here we assessed whether passively delivered AMMO1, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Swati, Homad, Leah J., Akins, Nicholas R., Stoffers, Claire M., Lackhar, Stefan, Malhi, Harman, Wan, Yu-Hsin, Rawlings, David J., McGuire, Andrew T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386402/
https://www.ncbi.nlm.nih.gov/pubmed/32724901
http://dx.doi.org/10.1016/j.xcrm.2020.100033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386402/
https://www.ncbi.nlm.nih.gov/pubmed/32724901
http://dx.doi.org/10.1016/j.xcrm.2020.100033

Ejemplares similares